This work is licensed under the Creative Commons Attribution 4.0 International License.
Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89:453-462.AzzizRSanchezLAKnochenhauerESMoranCLazenbyJStephensKCTaylorKBootsLRAndrogen excess in women: experience with over 1000 consecutive patientsJ Clin Endocrinol Metab20048945346210.1210/jc.2003-031122Search in Google Scholar
Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91:2-6.CarminaERosatoFJannìARizzoMLongoRA.Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenismJ Clin Endocrinol Metab2006912610.1210/jc.2005-1457Search in Google Scholar
Yildiz BO. Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab. 2006;20:167-176.YildizBODiagnosis of hyperandrogenism: clinical criteriaBest Pract Res Clin Endocrinol Metab20062016717610.1016/j.beem.2006.02.004Search in Google Scholar
Gibson DA, Simitsidellis I, Cousins FL, Critchley HOD, Saunders PTK. Intracrine androgens enhance decidualization and modulate expression of human endometrial receptivity genes. Sci Rep. 2016;6:19970.GibsonDASimitsidellisICousinsFLCritchleyHODSaundersPTKIntracrine androgens enhance decidualization and modulate expression of human endometrial receptivity genesSci Rep201661997010.1038/srep19970Search in Google Scholar
Gibson DA, Simitsidellis I, Collins F, Saunders PTK. Evidence of androgen action in endometrial and ovarian cancers. Endocr Relat Cancer. 2014;21:T203-T218.GibsonDASimitsidellisICollinsFSaundersPTKEvidence of androgen action in endometrial and ovarian cancersEndocr Relat Cancer201421T203T21810.1530/ERC-13-0551Search in Google Scholar
Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D’Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J, Gómez F, Medicherla S, Alfaro IE, McCullagh E, Jedlicka P, Torkko KC, Thor AD, Elias AD, Protter AA, Richer JK. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res. 2014;16:R7CochraneDRBernalesSJacobsenBMCittellyDMHoweEND’AmatoNCSpoelstraNSEdgertonSMJeanAGuerreroJGómezFMedicherlaSAlfaroIEMcCullaghEJedlickaPTorkkoKCThorADEliasADProtterAARicherJKRole of the androgen receptor in breast cancer and preclinical analysis of enzalutamideBreast Cancer Res201416R710.1186/bcr3599Search in Google Scholar
Mylonas I, Makovitzky J, Friese K, Jeschke U. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium. Acta Histochem. 2009;111:350-360.MylonasIMakovitzkyJFrieseKJeschkeUImmunohistochemical labelling of steroid receptors in normal and malignant human endometriumActa Histochem200911135036010.1016/j.acthis.2008.11.012Search in Google Scholar
Takeda H, Chodak G, Mutchnik S, Nakamoto T, Chang C. Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor. J Endocrinol. 1990;126:17-26.TakedaHChodakGMutchnikSNakamotoTChangCImmunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptorJ Endocrinol1990126172610.1677/joe.0.1260017Search in Google Scholar
Tuckerman EM, Okon MA, Li T-C, Laird SM. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril. 2000;74:771-779.TuckermanEMOkonMALiT-CLairdSMDo androgens have a direct effect on endometrial function? An in vitro studyFertil Steril20007477177910.1016/S0015-0282(00)00711-1Search in Google Scholar
Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002;20:3001-3015.GelmannEPMolecular biology of the androgen receptorJ Clin Oncol2002203001301510.1200/JCO.2002.10.01812089231Search in Google Scholar
Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001;1:34-45.FeldmanBJFeldmanDThe development of androgen-independent prostate cancerNat Rev Cancer20011344510.1038/3509400911900250Search in Google Scholar
Graham L, Schweizer MT. Targeting persistent androgen receptor signaling in castration-resistant prostate cancer. Med Oncol. 2016;33:44.GrahamLSchweizerMTTargeting persistent androgen receptor signaling in castration-resistant prostate cancerMed Oncol2016334410.1007/s12032-016-0759-327042852Search in Google Scholar
Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung H-J, Brodie AMH, Edwards J, Qiu Y. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res. 2009;69:2305-2313.GuoZYangXSunFJiangRLinnDEChenHChenHKongXMelamedJTepperCGKungH-JBrodieAMHEdwardsJQiuYA novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growthCancer Res2009692305231310.1158/0008-5472.CAN-08-3795267282219244107Search in Google Scholar
Nyquist MD, Dehm SM. Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression. Horm Cancer. 2013;4:61-69.NyquistMDDehmSMInterplay between genomic alterations and androgen receptor signaling during prostate cancer development and progressionHorm Cancer20134616910.1007/s12672-013-0131-4395709223307762Search in Google Scholar
Azoitei A, Merseburger AS, Godau B, Hoda MR, Schmid E, Cronauer MV. C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer. J Steroid Biochem Mol Biol. 2017;166:38-44.AzoiteiAMerseburgerASGodauBHodaMRSchmidECronauerMVC-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancerJ Steroid Biochem Mol Biol2017166384410.1016/j.jsbmb.2016.06.00827345700Search in Google Scholar
Sprenger CCT, Plymate SR. The link between androgen receptor splice variants and castration-resistant prostate cancer. Horm Cancer. 2014;5:207-217.SprengerCCTPlymateSRThe link between androgen receptor splice variants and castration-resistant prostate cancerHorm Cancer2014520721710.1007/s12672-014-0177-y430803524798453Search in Google Scholar
Xu J, Qiu Y. Role of androgen receptor splice variants in prostate cancer metastasis. Asian J Urol. 2016;3:177-184.XuJQiuYRole of androgen receptor splice variants in prostate cancer metastasisAsian J Urol2016317718410.1016/j.ajur.2016.08.003532517928239558Search in Google Scholar
Xu D, Zhan Y, Qi Y, Cao B, Bai S, Xu W, Gambhir SS, Lee P, Sartor O, Flemington EK, Zhang H, Hu C-D, Dong Y. Androgen receptor splice variants dimerize to transactivate target genes. Cancer Res. 2015;75:3663-3671.XuDZhanYQiYCaoBBaiSXuWGambhirSSLeePSartorOFlemingtonEKZhangHHuC-DDongYAndrogen receptor splice variants dimerize to transactivate target genesCancer Res2015753663367110.1158/0008-5472.CAN-15-0381455837626060018Search in Google Scholar
McCrea E, Sissung TM, Price DK, Chau CH, Figg WD. Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacol Res. 2016;114:152-162.McCreaESissungTMPriceDKChauCHFiggWDAndrogen receptor variation affects prostate cancer progression and drug resistancePharmacol Res201611415216210.1016/j.phrs.2016.10.001515481127725309Search in Google Scholar
Welti J, Rodrigues DN, Sharp A, Sun S, Lorente D, Riisnaes R, Figueiredo I, Zafeiriou Z, Rescigno P, de Bono JS, Plymate SR. Analytical validation and clinical qualification of a new immunohistochemical assay for androgen receptor splice variant-7 protein expression in metastatic castration-resistant prostate cancer. Eur Urol. 2016;70:599-608.WeltiJRodriguesDNSharpASunSLorenteDRiisnaesRFigueiredoIZafeiriouZRescignoPdeBono JSPlymateSR.Analytical validation and clinical qualification of a new immunohistochemical assay for androgen receptor splice variant-7 protein expression in metastatic castration-resistant prostate cancerEur Urol20167059960810.1016/j.eururo.2016.03.049501557527117751Search in Google Scholar
Ciccarese C, Santoni M, Brunelli M, Buti S, Modena A, Nabissi M, Artibani W, Martignoni G, Montironi R, Tortora G, Massari F. AR-V7 and prostate cancer: The watershed for treatment selection? Cancer Treat Rev. 2016;43:27-35.CiccareseCSantoniMBrunelliMButiSModenaANabissiMArtibaniWMartignoniGMontironiRTortoraGMassariFAR-V7 and prostate cancer: The watershed for treatment selection?Cancer Treat Rev201643273510.1016/j.ctrv.2015.12.003Search in Google Scholar
Hörnberg E, Ylitalo EB, Crnalic S, Antti H, Stattin P, Widmark A, Bergh A, Wikström P. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS ONE. 2011;6:e19059.HörnbergEYlitaloEBCrnalicSAnttiHStattinPWidmarkABerghAWikströmP.Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survivalPLoS ONE20116e1905910.1371/journal.pone.0019059Search in Google Scholar
Guo H, Li Y, Luo M, Lin S, Chen J, Ma Q, Gu Y, Jiang Z, Gui Y. Androgen receptor binding to an androgen-responsive element in the promoter of the Srsf4 gene inhibits its expression in mouse Sertoli cells. Mol Reprod Dev. 2015;82:976-985.GuoHLiYLuoMLinSChenJMaQGuYJiangZGuiYAndrogen receptor binding to an androgen-responsive element in the promoter of the Srsf4 gene inhibits its expression in mouse Sertoli cellsMol Reprod Dev20158297698510.1002/mrd.22576Search in Google Scholar
Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem. 1993;1;41:671-678.KimuraNMizokamiAOonumaTSasanoHNaguraHImmunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissuesJ Histochem Cytochem199314167167810.1177/41.5.8468448Search in Google Scholar
Hodgins MB, Spike RC, Mackie RM, MacLean AB. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol. 1998;105:216-222.HodginsMBSpikeRCMackieRMMacLeanABAn immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vaginaBr J Obstet Gynaecol199810521622210.1111/j.1471-0528.1998.tb10056.xSearch in Google Scholar
Kohlberger PD, Joura EA, Bancher D, Gitsch G, Breitenecker G, Kieback DG. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J Soc Gynecol Investig. 1998;5:331-333.KohlbergerPDJouraEABancherDGitschGBreiteneckerGKiebackDGEvidence of androgen receptor expression in lichen sclerosus: an immunohistochemical studyJ Soc Gynecol Investig1998533133310.1016/S1071-5576(98)00033-1Search in Google Scholar
Hu DG, Hickey TE, Irvine C, Wijayakumara DD, Lu L, Tilley WD, Selth LA, Mackenzie PI. Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues. Horm Cancer. 2014;5:61-71.HuDGHickeyTEIrvineCWijayakumaraDDLuLTilleyWDSelthLAMackenziePIIdentification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissuesHorm Cancer20145617110.1007/s12672-014-0171-424570075Search in Google Scholar
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-1447.FerrimanDGallweyJDClinical assessment of body hair growth in womenJ Clin Endocrinol Metab1961211440144710.1210/jcem-21-11-144013892577Search in Google Scholar
Rachoń D. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2012;120:205-209.RachońD.Differential diagnosis of hyperandrogenism in women with polycystic ovary syndromeExp Clin Endocrinol Diabetes201212020520910.1055/s-0031-129976522421986Search in Google Scholar
Stanczyk FZ. Diagnosis of hyperandrogenism: Biochemical criteria. Best Pract Res Clin Endocrinol Metab. 2006;20:177-191.StanczykFZDiagnosis of hyperandrogenism: Biochemical criteriaBest Pract Res Clin Endocrinol Metab20062017719110.1016/j.beem.2006.03.00716772150Search in Google Scholar
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456-488.AzzizRCarminaEDewaillyDDiamanti-KandarakisEEscobar-MorrealeHFFutterweitWJanssenOELegroRSNormanRJTaylorAEWitchelSFThe Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force reportFertil Steril20099145648810.1016/j.fertnstert.2008.06.03518950759Search in Google Scholar
Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 2002;66:297-304.ApparaoKBLovelyLPGuiYLiningerRALesseyBAElevated endometrial androgen receptor expression in women with polycystic ovarian syndromeBiol Reprod20026629730410.1095/biolreprod66.2.29711804942Search in Google Scholar
Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Mesquita D, Bueno HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, Gils V, H C, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E. Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst. 2005;97:755-765.KaaksRBerrinoFKeyTRinaldiSDossusLBiessyCSecretoGAmianoPBinghamSBoeingHMesquitaDBuenoHBChang-ClaudeJClavel-ChapelonFFournierAGilsVH CGonzalezCAGurreaABCritselisEKhawKTKroghVLahmannPHNagelGOlsenAOnland-MoretNCOvervadKPalliDPanicoSPeetersPQuirósJRRoddamAThiebautATjønnelandAChirlaqueMDTrichopoulouATrichopoulosDTuminoRVineisPNoratTFerrariPSlimaniNRiboliE.Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC)J Natl Cancer Inst20059775576510.1093/jnci/dji13215900045Search in Google Scholar
Chia K, O’Brien M, Brown M, Lim E. Targeting the androgen receptor in breast cancer. Curr Oncol Rep. 2015;17:4.ChiaKO’BrienMBrownMLimETargeting the androgen receptor in breast cancerCurr Oncol Rep201517410.1007/s11912-014-0427-825665553Search in Google Scholar
Iacopetta D, Rechoum Y, Fuqua SA. The role of androgen receptor in breast cancer. Drug Discov Today Dis Mech. 2012;9:e19-27.IacopettaDRechoumYFuquaSAThe role of androgen receptor in breast cancerDrug Discov Today Dis Mech20129e192710.1016/j.ddmec.2012.11.003464327926568765Search in Google Scholar
Mishra AK, Agrawal U, Negi S, Bansal A, Mohil R, Chintamani C, Bhatnagar A, Bhatnagar D, Saxena S. Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors. Indian J Med Res. 2012;135:843-852.MishraAKAgrawalUNegiSBansalAMohilRChintamaniCBhatnagarABhatnagarDSaxenaSExpression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factorsIndian J Med Res2012135843852Search in Google Scholar
Rampurwala M, Wisinski KB, O’Regan R. Role of the androgen receptor in triple-negative breast cancer. Clin Adv Hematol Oncol. 2016;14:186-193.RampurwalaMWisinskiKBO’ReganR.Role of the androgen receptor in triple-negative breast cancerClin Adv Hematol Oncol201614186193Search in Google Scholar
Wang F, Pan J, Liu Y, Meng Q, Lv P, Qu F, Ding G-L, Klausen C, Leung PCK, Chan HC, Yao W, Zhou C-Y, Shi B, Zhang J, Sheng J, Huang H. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci US A. 2015;112:4743-4748.WangFPanJLiuYMengQLvPQuFDingG-LKlausenCLeungPCKChanHCYaoWZhouC-YShiBZhangJShengJHuangHAlternative splicing of the androgen receptor in polycystic ovary syndromeProc Natl Acad Sci US A20151124743474810.1073/pnas.1418216112440315725825716Search in Google Scholar
Walters KA, Handelsman DJ. Androgen receptor splice variants and polycystic ovary syndrome: cause or effect? Asian J Androl 2016;18:442-443.WaltersKAHandelsmanDJAndrogen receptor splice variants and polycystic ovary syndrome: cause or effect?Asian J Androl20161844244310.4103/1008-682X.161600485410026306851Search in Google Scholar